32. Prevention: Clinical 1161-130

1161-130 - FACTORS THAT INFLUENCE BEMPEDOIC ACID-MEDIATED REDUCTIONS IN HIGH-SENSITIVITY C-REACTIVE PROTEIN: ANALYSIS OF POOLED PATIENT-LEVEL DATA FROM PHASE 3 CLINICAL TRIALS

Session
1161 - Prevention: Clinical 2
Speakers
Pathway
32. Prevention: Clinical
Presentation Number
1161-130
Presentation Rating
 |